Intravenous Immunoglobulin Market Worth $21.1 Billion By 2030
Intravenous Immunoglobulin Industry Overview The global intravenous immunoglobulin market size is expected to reach USD 21.1 billion by 2030, according to a new study by Grand View Research, Inc. It is expected to expand at a CAGR of 7.3% from 2022 to 2030. The increasing prevalence of immunodeficiency diseases, coupled with the adoption of intravenous immunoglobulin (IVIG) therapies, is expected to fuel market growth over the forecast period. In addition, increasing off-label use of immunoglobulin and investments in the healthcare sector are factors propelling the market growth. Moreover, increasing incidences of bleeding disorders and the growing geriatric population are the factors contributing to the industry growth. Intravenous Immunoglobulin Market Segmentation Grand View Research has segmented the global intravenous immunoglobulin market on the basis of application, distribution channel, and region: Based on the Application Insights, the market is segmented into ...